Evidence map›Paper›PMID 31455529›Full record

ArticleMethods in enzymology2019

Protein interactions of the inflammasome adapter ASC by solution NMR.

Pedro Diaz-Parga, Eva de Alba

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pedro Diaz-PargaDepartment of Bioengineering, School of Engineering, University of California, Merced, CA, United States; Quantitative Systems Biology Graduate Program, University of California, Merced, CA, United States.
Eva de AlbaDepartment of Bioengineering, School of Engineering, University of California, Merced, CA, United States. Electronic address: edealbabastarrechea@ucmerced.edu.
University of California, Merced · US

Funding

Molecular Bases of Inflammasome Regulation Mediated by ASC IsoformsR15AI146780 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI DE ALBA BASTARRECHEA, EVA · 2019 to 2020
$580k
NIAID NIH HHS R15 AI146780
6 · The paper itself

Abstract

ASC (apoptosis-associated speck-like protein containing a CARD) is a modular protein that functions as an adapter of the inflammasome, a multi-protein complex that triggers the inflammatory response in the presence of infection or cell damage. ASC bridges the inflammasome components (PYD-containing sensors and procaspase 1) via homotypic interactions mediated by its two death domains, PYD and CARD. The self-assembly and oligomerization of multiple copies of these three proteins result in the activation of procaspase 1, in turn rendering different cytokines functional. An in-depth understanding of ASC binding capabilities is crucial to decipher the molecular mechanisms of its role in inflammasome formation. In this chapter, we discuss the use of solution NMR to identify specific interacting surfaces of the inflammasome adapter ASC, and describe detailed protocols to perform NMR titrations with Death Domains to obtain apparent dissociation constants of the resulting complexes. The incorporation of NMR restraints in molecular docking to obtain models of these protein assemblies is presented.

Indexed as

AnimalsHumansInflammasomesMagnetic Resonance SpectroscopyMolecular Docking SimulationNLR Family, Pyrin Domain-Containing 3 ProteinProtein BindingInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinASCCARDDeath domainInflammasomeInflammationNLRP3NMRProtein assemblyPYD

Identifiers

PMID31455529
PMCPMC8455076
OpenAlexW2967887342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.